{
    "2019-07-22": [
        [
            {
                "time": "2019-07-22",
                "original_text": "渝股看台｜智飞生物大股东9折让利员工持股计划，6.6亿元出售1600万股",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "大股东减持",
                        "员工持股计划",
                        "9折让利",
                        "6.6亿元"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-22",
                "original_text": "智飞生物实控人让利员工持股计划 800名员工斥资6.6亿元认购1600万股",
                "features": {
                    "keywords": [
                        "实控人蒋仁生",
                        "员工持股计划",
                        "800名员工",
                        "6.6亿元",
                        "1600万股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-22",
                "original_text": "智飞生物：员工持股计划接盘大股东1600万股股份",
                "features": {
                    "keywords": [
                        "员工持股计划",
                        "接盘",
                        "大股东减持",
                        "1600万股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-07-22",
                "original_text": "智飞生物(300122.SZ)：实际控制人蒋仁生减持1600万股 由员工持股计划买入",
                "features": {
                    "keywords": [
                        "实际控制人蒋仁生",
                        "减持",
                        "员工持股计划",
                        "1600万股"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-07-22",
                "original_text": "智飞生物：第二期员工持股计划受让1600万股 耗资6.6亿元",
                "features": {
                    "keywords": [
                        "第二期员工持股计划",
                        "受让",
                        "1600万股",
                        "6.6亿元"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-22",
                "original_text": "[快讯]智飞生物:关于第二期员工持股计划实施进展暨公司控股股东减持股份 拟减持股份",
                "features": {
                    "keywords": [
                        "第二期员工持股计划",
                        "控股股东减持",
                        "拟减持股份"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-07-22",
                "original_text": "智飞生物：控股股东减持1600万股，公司第二期员工持股计划接盘 减持股份",
                "features": {
                    "keywords": [
                        "控股股东减持",
                        "第二期员工持股计划",
                        "接盘",
                        "1600万股"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}